To view the PDF file, sign up for a MySharenet subscription.

ASPEN PHARMACARE HOLDINGS LIMITED - Dealing in securities by Directors, Company Secretary and Prescribed Officers of the company

Release Date: 27/10/2021 10:02
Code(s): APN     PDF:  
Wrap Text
Dealing in securities by Directors, Company Secretary and Prescribed Officers of the company

ASPEN PHARMACARE HOLDINGS LIMITED
(Incorporated in the Republic of South Africa) (“Aspen Holdings”)
Registration number: 1985/002935/06
Share code: APN
ISIN: ZAE000066692
LEI: 635400ZYSN1IRD5QWQ94
and its subsidiaries (collectively “Aspen” or “the Group”)




DEALING IN SECURITIES BY DIRECTORS, COMPANY SECRETARY AND PRESCRIBED OFFICERS OF THE
COMPANY

In compliance with paragraph 3.63 of the Listings Requirements of the JSE Limited, disclosure is made of
the following information:

DIRECTORS OF THE COMPANY

Director                      :    Stephen Bradley Saad
Date of transaction           :    26 October 2021
Nature of transaction         :    Acceptance of deferred incentive bonus shares (vesting after three years)
Date of award                 :    31 August 2021 (JSE dispensation obtained for award to be accepted while
                                   Aspen Holdings trades under a cautionary announcement)
Number of securities          :    20 798
Class of securities           :    Ordinary shares
Grant price                   :    R194.44
Value of Transaction          :    R 4 043 963.12
Nature of interest            :    Direct beneficial
Clearance obtained            :    Yes

Director                      :    Michael Guy Attridge
Date of transaction           :    26 October 2021
Nature of transaction         :    Acceptance of deferred incentive bonus shares (vesting after three years)
Date of award                 :    31 August 2021 (JSE dispensation obtained for award to be accepted while
                                   Aspen Holdings trades under a cautionary announcement)
Number of securities          :    17 193
Class of securities           :    Ordinary shares
Grant price                   :    R194.44
Value of Transaction          :    R 3 343 006.92
Nature of interest            :    Direct beneficial
Clearance obtained            :    Yes

COMPANY SECRETARY OF THE COMPANY

Company Secretary             :   Riaan Verster
Date of transaction           :   26 October 2021
Nature of transaction         :   Acceptance of deferred incentive bonus shares (vesting after three years)
Date of award                 :   31 August 2021 (JSE dispensation obtained for award to be accepted while     
                                  Aspen Holdings trades under a cautionary announcement)
Number of securities          :   4 271
Class of securities           :   Ordinary shares
Grant price                   :   R194.44
Value of Transaction          :   R 830 453.24
Nature of interest            :   Direct beneficial
Clearance obtained            :   Yes

PRESCRIBED OFFICERS OF THE COMPANY

Prescribed Officer            :   Sean Matthew Capazorio
Date of transaction           :   26 October 2021
Nature of transaction         :   Acceptance of deferred incentive bonus shares (vesting after three years)
Date of award                 :   31 August 2021 (JSE dispensation obtained for award to be accepted while           
                                  Aspen Holdings trades under a cautionary announcement)
Number of securities          :   9 836
Class of securities           :   Ordinary shares
Grant price                   :   R194.44
Value of Transaction          :   R 1 912 511.84
Nature of interest            :   Direct beneficial
Clearance obtained            :   Yes

Prescribed Officer            :   Reginald Haman
Date of transaction           :   26 October 2021
Nature of transaction         :   Acceptance of deferred incentive bonus shares (vesting after three years)
Date of award                 :   31 August 2021 (JSE dispensation obtained for award to be accepted while           
                                  Aspen Holdings trades under a cautionary announcement)
Number of securities          :   8 098
Class of securities           :   Ordinary shares
Grant price                   :   R194.44
Value of Transaction          :   R 1 574 575.12
Nature of interest            :   Direct beneficial
Clearance obtained            :   Yes

Prescribed Officer            :   Lorraine Angela Hill
Date of transaction           :   26 October 2021
Nature of transaction         :   Acceptance of deferred incentive bonus shares (vesting after three years)
Date of award                 :   31 August 2021 (JSE dispensation obtained for award to be accepted while           
                                  Aspen Holdings trades under a cautionary announcement)
Number of securities          :   14 125
Class of securities           :   Ordinary shares
Grant price                   :   R194.44
Value of Transaction          :   R 2 746 465.00
Nature of interest            :   Direct beneficial
Clearance obtained            :   Yes

Prescribed Officer            :   Zizipho Mmango
Date of transaction           :   26 October 2021
Nature of transaction         :   Acceptance of deferred incentive bonus shares (vesting after three years)
Date of award                 :   31 August 2021 (JSE dispensation obtained for award to be accepted while
                                  Aspen Holdings trades under a cautionary announcement)
Number of securities          :   8 709
Class of securities           :   Ordinary shares
Grant price                   :   R194.44
Value of Transaction          :   R 1 693 377.96
Nature of interest            :   Direct beneficial
Clearance obtained            :   Yes


All acceptances of deferred bonus shares are deemed to be off-market trades.
Durban
27 October 2021
Sponsor
Investec Bank Limited

Date: 27-10-2021 10:02:00
Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). 
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
 the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, 
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
 information disseminated through SENS.